In Pursuit of Fluorinated Sigma Receptor Ligand Candidates Related to [18F]-FPS

2019 ◽  
Vol 72 (3) ◽  
pp. 213 ◽  
Author(s):  
Rasha S. Jwad ◽  
Alan H. C. Pang ◽  
Luke Hunter ◽  
Roger W. Read

This paper describes the synthesis of N-arylmethyl(1-benzyl) and N-aroyl(1-benzoyl) 4-(4-fluoromethylphenoxymethyl)piperidines as potential sigma receptor ligands analogous to the potent and highly selective sigma-1 ligand [18F]-FPS, but with enhanced or alternative binding and transport profiles. The synthesis involves N-aroylation of 4-hydroxmethylpiperidine or ethyl nipecotate, functional group manipulation of the ester group or simple activation of the hydroxyl group to introduce the phenoxy component, and subsequent functional group manipulation to reduce the amide group and introduce the fluorine into the fluoromethyl substituent. In its development, the synthesis was found to require early N-aroylation of the piperidine precursor to avoid complications due to anchimeric assistance by its nitrogen in subsequent displacement reactions. New evidence is presented on the pathway followed in a literature report of direct displacement of a benzylic hydroxyl group by fluoride ion under Appel-like conditions. Relevant to the literature report, the halide ion in the fluoromethylphenoxy 1-benzylpiperidine derivatives was surprisingly labile to hydrolytic displacement on chromatography and this aspect is worthy of further study. Moreover, the NMR spectra of the amides were complicated by geometric isomerism about the amide C(O)–N bond, but detailed analysis of spectra from 2-anisoyl derivatives allowed the assignment of diastereomeric contributors to consistent, secondary atropisomerism about the aryl–C(O) bond.

Pathogens ◽  
2021 ◽  
Vol 10 (11) ◽  
pp. 1514
Author(s):  
David A. Ostrov ◽  
Andrew P. Bluhm ◽  
Danmeng Li ◽  
Juveriya Qamar Khan ◽  
Megha Rohamare ◽  
...  

(1) Background: There is a strong need for prevention and treatment strategies for COVID-19 that are not impacted by SARS-CoV-2 mutations emerging in variants of concern. After virus infection, host ER resident sigma receptors form direct interactions with non-structural SARS-CoV-2 proteins present in the replication complex. (2) Methods: In this work, highly specific sigma receptor ligands were investigated for their ability to inhibit both SARS-CoV-2 genome replication and virus induced cellular toxicity. This study found antiviral activity associated with agonism of the sigma-1 receptor (e.g., SA4503), ligation of the sigma-2 receptor (e.g., CM398), and a combination of the two pathways (e.g., AZ66). (3) Results: Intermolecular contacts between these ligands and sigma receptors were identified by structural modeling. (4) Conclusions: Sigma receptor ligands and drugs with off-target sigma receptor binding characteristics were effective at inhibiting SARS-CoV-2 infection in primate and human cells, representing a potential therapeutic avenue for COVID-19 prevention and treatment.


Author(s):  
Antonino N. Fallica ◽  
Valeria Pittalà ◽  
Maria N. Modica ◽  
Loredana Salerno ◽  
Giuseppe Romeo ◽  
...  

2009 ◽  
Vol 23 (S1) ◽  
Author(s):  
Gianluigi Tanda ◽  
Linda Garcés‐Ramírez ◽  
Jennifer L Green ◽  
Takato Hiranita ◽  
Jonathan L Katz

2015 ◽  
Vol 1848 (10) ◽  
pp. 2703-2714 ◽  
Author(s):  
Aren van Waarde ◽  
Anna A. Rybczynska ◽  
Nisha K. Ramakrishnan ◽  
Kiichi Ishiwata ◽  
Philip H. Elsinga ◽  
...  

1997 ◽  
Vol 24 (6) ◽  
pp. 587-593 ◽  
Author(s):  
Rikki N. Waterhouse ◽  
Janette Chapman ◽  
Beverley Izard ◽  
Angela Donald ◽  
Kerynne Belbin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document